Teva Pharmaceutical Industries Ltd (NYSE:TEVA)‘s stock had its “buy” rating restated by research analysts at Oppenheimer Holdings Inc. in a research report issued to clients and investors on Wednesday. Several other analysts have also recently weighed in on the stock. Zacks Investment Research raised shares of Teva Pharmaceutical Industries from a “sell” rating to a […]
